Table 1a.
Patient and Transplant Characteristics
| Variable | Median (Range) or N (%) |
|---|---|
| Patient Age at HCT | 49 (18 – 70) |
| Patient Gender | |
| Female | 140 (51) |
| Male | 136 (49) |
| Year of HCT | |
| Before 2005 | 102 (37) |
| After 2005 | 174 (63) |
| Donor Type | |
| Sibling | 190 (69) |
| Unrelated | 86 (31) |
| Donor/Patient Gender | |
| Female Donor to Male Patient | 48 (17) |
| Other | 228 (83) |
| Cytogenetic Risk | |
| Favorable | 13 (5) |
| Intermediate | 165 (60) |
| Unfavorable | 69 (25) |
| Unknown/NA | 29 (10) |
| Stem Cell Sources | |
| BM | 36 (13) |
| PBSC | 240 (87) |
| Disease Status at HCT | |
| CR1 | 229 (83) |
| CR2 | 47 (17) |
| Donor/Patient CMV Status | |
| Negative/Negative | 34 (12) |
| Negative/Positive | 59 (21) |
| Positive/Negative | 29 (11) |
| Positive/Positive | 154 (56) |
| GVHD Prophylaxis | |
| Cyclosporine + 1 Drug | 75 (27) |
| Cyclosporine + 2/3 Drugs | 27 (10) |
| Tacro + 1 Drug | 154 (56) |
| Tacro + 2/3 Drugs | 20 (7) |
| Tacro/Siro Usage | |
| No | 114 (41) |
| Yes | 162 (59) |
| Conditioning Regimens | |
| Flu/Mel | 125 (45) |
| Other | 151 (55) |
| ABO compatibility | |
| Match | 165 (60) |
| Not-matched | 111 (40) |